DexCom (DXCM) G7 Receives FDA Clearance: The Most Accurate Continuous Glucose Monitoring System Cleared in the U.S.
Go back to DexCom (DXCM) G7 Receives FDA Clearance: The Most Accurate Continuous Glucose Monitoring System Cleared in the U.S.DexCom, Inc. (NASDAQ: DXCM) | Delayed: 138.01 +0.14 (0.10%) | |||||
---|---|---|---|---|---|---|
Previous Close | $137.87 | 52 Week High | $96.38 | |||
Open | $138.91 | 52 Week Low | $47.92 | |||
Day High | $139.24 | P/E | N/A | |||
Day Low | $134.39 | EPS | $-0.42 | |||
Volume | 4,203,060 |